A citation-based method for searching scientific literature

Maeve A Lowery, Winston Wong, Emmet J Jordan, Jonathan W Lee, Yelena Kemel, Joseph Vijai, Diana Mandelker, Ahmet Zehir, Marinela Capanu, Erin Salo-Mullen, Angela G Arnold, Kenneth H Yu, Anna M Varghese, David P Kelsen, Robin Brenner, Erica Kaufmann, Vignesh Ravichandran, Semanti Mukherjee, Michael F Berger, David M Hyman, David S Klimstra, Ghassan K Abou-Alfa, Catherine Tjan, Christina Covington, Hannah Maynard, Peter J Allen, Gokce Askan, Steven D Leach, Christine A Iacobuzio-Donahue, Mark E Robson, Kenneth Offit, Zsofia K Stadler, Eileen M O'Reilly. J Natl Cancer Inst 2018
Times Cited: 99







List of co-cited articles
827 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh,[...]. N Engl J Med 2019
805
52

Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
Koji Shindo, Jun Yu, Masaya Suenaga, Shahriar Fesharakizadeh, Christy Cho, Anne Macgregor-Das, Abdulrehman Siddiqui, P Dane Witmer, Koji Tamura, Tae Jun Song,[...]. J Clin Oncol 2017
202
47

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
Chunling Hu, Steven N Hart, Eric C Polley, Rohan Gnanaolivu, Hermela Shimelis, Kun Y Lee, Jenna Lilyquist, Jie Na, Raymond Moore, Samuel O Antwi,[...]. JAMA 2018
222
39

Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.
Matthew B Yurgelun, Anu B Chittenden, Vicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne, Margaret M Kozak, Zhi Rong Qian, Marisa W Welch, Lauren K Brais, Annacarolina Da Silva,[...]. Genet Med 2019
94
31

Whole genomes redefine the mutational landscape of pancreatic cancer.
Nicola Waddell, Marina Pajic, Ann-Marie Patch, David K Chang, Karin S Kassahn, Peter Bailey, Amber L Johns, David Miller, Katia Nones, Kelly Quek,[...]. Nature 2015
28

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.
T Golan, Z S Kanji, R Epelbaum, N Devaud, E Dagan, S Holter, D Aderka, S Paluch-Shimon, B Kaufman, R Gershoni-Baruch,[...]. Br J Cancer 2014
237
27

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Thierry Conroy, Françoise Desseigne, Marc Ychou, Olivier Bouché, Rosine Guimbaud, Yves Bécouarn, Antoine Adenis, Jean-Luc Raoul, Sophie Gourgou-Bourgade, Christelle de la Fouchardière,[...]. N Engl J Med 2011
27

Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Spring Holter, Ayelet Borgida, Anna Dodd, Robert Grant, Kara Semotiuk, David Hedley, Neesha Dhani, Steven Narod, Mohammad Akbari, Malcolm Moore,[...]. J Clin Oncol 2015
226
26

Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.
Robert C Grant, Iris Selander, Ashton A Connor, Shamini Selvarajah, Ayelet Borgida, Laurent Briollais, Gloria M Petersen, Jordan Lerner-Ellis, Spring Holter, Steven Gallinger. Gastroenterology 2015
182
24

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Diana Mandelker, Liying Zhang, Yelena Kemel, Zsofia K Stadler, Vijai Joseph, Ahmet Zehir, Nisha Pradhan, Angela Arnold, Michael F Walsh, Yirong Li,[...]. JAMA 2017
227
24

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
Daniel D Von Hoff, Thomas Ervin, Francis P Arena, E Gabriela Chiorean, Jeffrey Infante, Malcolm Moore, Thomas Seay, Sergei A Tjulandin, Wen Wee Ma, Mansoor N Saleh,[...]. N Engl J Med 2013
24

Identification of germline genetic mutations in patients with pancreatic cancer.
Erin E Salo-Mullen, Eileen M O'Reilly, David P Kelsen, Asad M Ashraf, Maeve A Lowery, Kenneth H Yu, Diane L Reidy, Andrew S Epstein, Anne Lincoln, Amethyst Saldia,[...]. Cancer 2015
114
24

BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
David B Zhen, Kari G Rabe, Steven Gallinger, Sapna Syngal, Ann G Schwartz, Michael G Goggins, Ralph H Hruban, Michele L Cote, Robert R McWilliams, Nicholas J Roberts,[...]. Genet Med 2015
158
23

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation.
Eileen M O'Reilly, Jonathan W Lee, Mark Zalupski, Marinela Capanu, Jennifer Park, Talia Golan, Esther Tahover, Maeve A Lowery, Joanne F Chou, Vaibhav Sahai,[...]. J Clin Oncol 2020
128
23

ATM mutations in patients with hereditary pancreatic cancer.
Nicholas J Roberts, Yuchen Jiao, Jun Yu, Levy Kopelovich, Gloria M Petersen, Melissa L Bondy, Steven Gallinger, Ann G Schwartz, Sapna Syngal, Michele L Cote,[...]. Cancer Discov 2012
311
22

Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
Randall Brand, Erkut Borazanci, Virginia Speare, Beth Dudley, Eve Karloski, Mary Linton B Peters, Lindsey Stobie, Nathan Bahary, Herbert Zeh, Amer Zureikat,[...]. Cancer 2018
41
51

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Lola Rahib, Benjamin D Smith, Rhonda Aizenberg, Allison B Rosenzweig, Julie M Fleshman, Lynn M Matrisian. Cancer Res 2014
21

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma.
Maeve A Lowery, David P Kelsen, Marinela Capanu, Sloane C Smith, Jonathan W Lee, Zsofia K Stadler, Malcolm J Moore, Hedy L Kindler, Talia Golan, Amiel Segal,[...]. Eur J Cancer 2018
97
20

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
20

Genomic analyses identify molecular subtypes of pancreatic cancer.
Peter Bailey, David K Chang, Katia Nones, Amber L Johns, Ann-Marie Patch, Marie-Claude Gingras, David K Miller, Angelika N Christ, Tim J C Bruxner, Michael C Quinn,[...]. Nature 2016
20

Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Hans Vasen, Isaura Ibrahim, Carmen Guillen Ponce, Emily P Slater, Elvira Matthäi, Alfredo Carrato, Julie Earl, Kristin Robbers, Anneke M van Mil, Thomas Potjer,[...]. J Clin Oncol 2016
190
19

Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.
Nicholas J Roberts, Alexis L Norris, Gloria M Petersen, Melissa L Bondy, Randall Brand, Steven Gallinger, Robert C Kurtz, Sara H Olson, Anil K Rustgi, Ann G Schwartz,[...]. Cancer Discov 2016
191
19

Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
Kari G Chaffee, Ann L Oberg, Robert R McWilliams, Neil Majithia, Brian A Allen, John Kidd, Nanda Singh, Anne-Renee Hartman, Richard J Wenstrup, Gloria M Petersen. Genet Med 2018
69
27

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.
Bella Kaufman, Ronnie Shapira-Frommer, Rita K Schmutzler, M William Audeh, Michael Friedlander, Judith Balmaña, Gillian Mitchell, Georgeta Fried, Salomon M Stemmer, Ayala Hubert,[...]. J Clin Oncol 2015
18

Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.
Chunling Hu, Steven N Hart, William R Bamlet, Raymond M Moore, Kannabiran Nandakumar, Bruce W Eckloff, Yean K Lee, Gloria M Petersen, Robert R McWilliams, Fergus J Couch. Cancer Epidemiol Biomarkers Prev 2016
80
21

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
17

Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Marcia Irene Canto, Jose Alejandro Almario, Richard D Schulick, Charles J Yeo, Alison Klein, Amanda Blackford, Eun Ji Shin, Abanti Sanyal, Gayane Yenokyan, Anne Marie Lennon,[...]. Gastroenterology 2018
151
17

Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation.
Rachna T Shroff, Andrew Hendifar, Robert R McWilliams, Ravit Geva, Ron Epelbaum, Lindsey Rolfe, Sandra Goble, Kevin K Lin, Andrew V Biankin, Heidi Giordano,[...]. JCO Precis Oncol 2018
101
17

Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
Elena M Stoffel, Shannon E McKernin, Randall Brand, Marcia Canto, Michael Goggins, Cassadie Moravek, Arun Nagarajan, Gloria M Petersen, Diane M Simeone, Matthew Yurgelun,[...]. J Clin Oncol 2019
69
24

Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.
Alison P Klein, Kieran A Brune, Gloria M Petersen, Michael Goggins, Anne C Tersmette, G Johan A Offerhaus, Constance Griffin, John L Cameron, Charles J Yeo, Scott Kern,[...]. Cancer Res 2004
416
16

Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine.
Andrew J Aguirre, Jonathan A Nowak, Nicholas D Camarda, Richard A Moffitt, Arezou A Ghazani, Mehlika Hazar-Rethinam, Srivatsan Raghavan, Jaegil Kim, Lauren K Brais, Dorisanne Ragon,[...]. Cancer Discov 2018
149
16

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.
Siân Jones, Ralph H Hruban, Mihoko Kamiyama, Michael Borges, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Emily Palmisano, Kieran Brune, Elizabeth M Jaffee,[...]. Science 2009
547
15

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.
Michael J Pishvaian, Edik M Blais, Jonathan R Brody, Emily Lyons, Patricia DeArbeloa, Andrew Hendifar, Sam Mikhail, Vincent Chung, Vaibhav Sahai, Davendra P S Sohal,[...]. Lancet Oncol 2020
161
15

Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.
Zishuo I Hu, Jinru Shia, Zsofia K Stadler, Anna M Varghese, Marinela Capanu, Erin Salo-Mullen, Maeve A Lowery, Luis A Diaz, Diana Mandelker, Kenneth H Yu,[...]. Clin Cancer Res 2018
185
14

Risk of pancreatic cancer in families with Lynch syndrome.
Fay Kastrinos, Bhramar Mukherjee, Nabihah Tayob, Fei Wang, Jennifer Sparr, Victoria M Raymond, Prathap Bandipalliam, Elena M Stoffel, Stephen B Gruber, Sapna Syngal. JAMA 2009
300
14

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.
Andrew V Biankin, Nicola Waddell, Karin S Kassahn, Marie-Claude Gingras, Lakshmi B Muthuswamy, Amber L Johns, David K Miller, Peter J Wilson, Ann-Marie Patch, Jianmin Wu,[...]. Nature 2012
14



International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
Marcia Irene Canto, Femme Harinck, Ralph H Hruban, George Johan Offerhaus, Jan-Werner Poley, Ihab Kamel, Yung Nio, Richard S Schulick, Claudio Bassi, Irma Kluijt,[...]. Gut 2013
458
13

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
13

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
Siân Jones, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Rebecca J Leary, Philipp Angenendt, Parminder Mankoo, Hannah Carter, Hirohiko Kamiyama, Antonio Jimeno,[...]. Science 2008
13

Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.
Ashton A Connor, Robert E Denroche, Gun Ho Jang, Lee Timms, Sangeetha N Kalimuthu, Iris Selander, Treasa McPherson, Gavin W Wilson, Michelle A Chan-Seng-Yue, Ivan Borozan,[...]. JAMA Oncol 2017
156
13

Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype.
Maeve A Lowery, Emmet J Jordan, Olca Basturk, Ryan N Ptashkin, Ahmet Zehir, Michael F Berger, Tanisha Leach, Brian Herbst, Gokce Askan, Hannah Maynard,[...]. Clin Cancer Res 2017
98
13

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
Thierry Conroy, Pascal Hammel, Mohamed Hebbar, Meher Ben Abdelghani, Alice C Wei, Jean-Luc Raoul, Laurence Choné, Eric Francois, Pascal Artru, James J Biagi,[...]. N Engl J Med 2018
13

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
Michael Goggins, Kasper Alexander Overbeek, Randall Brand, Sapna Syngal, Marco Del Chiaro, Detlef K Bartsch, Claudio Bassi, Alfredo Carrato, James Farrell, Elliot K Fishman,[...]. Gut 2020
155
13

Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
Aatur D Singhi, Ben George, Joel R Greenbowe, Jon Chung, James Suh, Anirban Maitra, Samuel J Klempner, Andrew Hendifar, Javle M Milind, Talia Golan,[...]. Gastroenterology 2019
117
12

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
12

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
790
11

An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions.
Maeve A Lowery, David P Kelsen, Zsofia K Stadler, Kenneth H Yu, Yelena Y Janjigian, Emmy Ludwig, David R D'Adamo, Erin Salo-Mullen, Mark E Robson, Peter J Allen,[...]. Oncologist 2011
165
11

Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial.
Kyaw L Aung, Sandra E Fischer, Robert E Denroche, Gun-Ho Jang, Anna Dodd, Sean Creighton, Bernadette Southwood, Sheng-Ben Liang, Dianne Chadwick, Amy Zhang,[...]. Clin Cancer Res 2018
227
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.